Dementia risk and prevention by targeting modifiable vascular risk factors

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Journal of Neurochemistry

• Publication date

  2018-03-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.1111/jnc.14132PMID 28734089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Vascular cognitive impairment

  2018cited by this paper
• Use of MRI to identify preclinical vascular dementia in symptomatic small vessel disease

  2017cited by this paper
• Trends in diagnosis and treatment for people with dementia in the UK from 2005 to 2015: a longitudinal retrospective cohort study.

  2017cited by this paper
• The Role of Cardiovascular Risk Factors and Stroke in Familial Alzheimer Disease.

  2016cited by this paper
• Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer’s disease

  2016cited by this paper
• High-resolution characterization of the aging brain using simultaneous quantitative susceptibility mapping ( QSM ) and R 2 * measurements at 7 Tesla

  2016cited by this paper
• White matter hyperintensities are a core feature of Alzheimer's disease: Evidence from the dominantly inherited Alzheimer network

  2016cited by this paper
• High-resolution characterisation of the aging brain using simultaneous quantitative susceptibility mapping (QSM) and R2* measurements at 7 T

  2016cited by this paper
• Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer’s Dementia Using Quantitative Susceptibility Mapping Imaging

  2016cited by this paper
• Defeating Alzheimer's disease and other dementias: a priority for European science and society.

  2016influential reference
• CAIDE Dementia Risk Score and biomarkers of neurodegeneration in memory clinic patients without dementia.

  2016cited by this paper
• The amyloid hypothesis of Alzheimer's disease at 25 years

  2016cited by this paper
• Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives

  2016cited by this paper
• Novel application of a discrete choice experiment to identify preferences for a national healthcare-associated infection surveillance programme: a cross-sectional study

  2016cited by this paper
• Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.

  2016cited by this paper
• Recent global trends in the prevalence and incidence of dementia, and survival with dementia

  2016cited by this paper
• Concurrent white and gray matter degeneration of disease-specific networks in early-stage Alzheimer's disease and behavioral variant frontotemporal dementia.

  2016cited by this paper
• Reduce vascular risk to prevent dementia?

  2016cited by this paper
• Healthy Ageing Through Internet Counselling in the Elderly: the HATICE randomised controlled trial for the prevention of cardiovascular disease and cognitive impairment

  2016cited by this paper
• Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial.

  2016influential reference
• Cognitive/Clinical Endpoints for Pre-Dementia AD Trials.

  2015cited by this paper
• Age- and education-adjusted normative data for the Montreal Cognitive Assessment (MoCA) in older adults age 70–99

  2015cited by this paper
• Is the risk of Alzheimer’s disease and dementia declining?

  2015cited by this paper
• Iron accumulation in the basal ganglia in Huntington's disease: cross-sectional data from the IMAGE-HD study

  2015cited by this paper
• Diffusion imaging changes in grey matter in Alzheimer’s disease: a potential marker of early neurodegeneration

  2015cited by this paper
• Reconsidering harbingers of dementia: progression of parietal lobe white matter hyperintensities predicts Alzheimer's disease incidence.

  2015cited by this paper
• Biomarkers in vascular dementia: A recent update

  2015cited by this paper
• Vascular dementia.

  2015cited by this paper
• Chronic Ischemia Alters Brain Microstructural Integrity and Cognitive Performance in Adult Moyamoya Disease

  2015cited by this paper
• When endothelial cells go rogue

  2015cited by this paper
• Summary of the evidence on modifiable risk factors for cognitive decline and dementia: A population‐based perspective

  2015influential reference
• A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial.

  2015influential reference
• Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease

  2015cited by this paper
• Validation of quantitative susceptibility mapping with Perls' iron staining for subcortical gray matter

  2015cited by this paper
• Alterations in the gray matter volume in transient ischemic attack: a voxel-based morphometry study

  2015cited by this paper
• APOE genotype and neuroimaging markers of Alzheimer's disease: systematic review and meta-analysis

  2014cited by this paper
• Multi-Scale Glycemic Variability: A Link to Gray Matter Atrophy and Cognitive Decline in Type 2 Diabetes

  2014cited by this paper
• Cognitive and Functional Decline and Their Relationship in Patients with Mild Alzheimer's Dementia

  2014influential reference
• MAPT STUDY: A MULTIDOMAIN APPROACH FOR PREVENTING ALZHEIMER'S DISEASE: DESIGN AND BASELINE DATA.

  2014cited by this paper
• Operationalizing hippocampal volume as an enrichment biomarker for amnestic mild cognitive impairment trials: effect of algorithm, test-retest variability, and cut point on trial cost, duration, and sample size.

  2014cited by this paper
• White matter integrity determined with diffusion tensor imaging in older adults without dementia: influence of amyloid load and neurodegeneration.

  2014influential reference
• Harmonized diagnostic criteria for Alzheimer's disease: recommendations

  2014cited by this paper
• Persistent Cognitive Impairment After Transient Ischemic Attack

  2014cited by this paper
• Biomarkers in dementia: clinical utility and new directions

  2014cited by this paper
• The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial

  2014cited by this paper
• Potential for primary prevention of Alzheimer's disease: an analysis of population-based data.

  2014cited by this paper
• Imaging Brain Metabolism and Pathology in Alzheimer’s Disease with Positron Emission Tomography

  2014influential reference
• Quantitative Susceptibility Mapping by Inversion of a Perturbation Field Model: Correlation With Brain Iron in Normal Aging

  2014cited by this paper
• Iron deposits in post‐mortem brains of patients with neurodegenerative and cerebrovascular diseases: a semi‐quantitative 7.0 T magnetic resonance imaging study

  2014cited by this paper
• World Alzheimer Report 2014: Dementia and risk reduction: An analysis of protective and modifiable risk factors

  2014cited by this paper
• Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer's disease.

  2014influential reference
• The overlap between vascular disease and Alzheimer’s disease - lessons from pathology

  2014cited by this paper
• Advances in the prevention of Alzheimer's disease and dementia

  2014cited by this paper
• A phase 3 trial of semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• Does combined cognitive training and physical activity training enhance cognitive abilities more than either alone? A four-condition randomized controlled trial among healthy older adults

  2013cited by this paper
• Targeted Recruitment Using Cerebrospinal Fluid Biomarkers: Implications for Alzheimer's Disease Therapeutic Trials

  2013cited by this paper
• MRI for Iron Mapping in Alzheimer's Disease

  2013influential reference
• MRI-visible perivascular spaces: relationship to cognition and small vessel disease MRI markers in ischaemic stroke and TIA

  2013cited by this paper
• Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers.

  2013cited by this paper
• Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials

  2013cited by this paper
• In Vivo Quantitative Susceptibility Mapping (QSM) in Alzheimer's Disease

  2013cited by this paper
• Spatial navigational strategies correlate with gray matter in the hippocampus of healthy older adults tested in a virtual maze

  2013cited by this paper
• Immunomodulatory Effects in a Phase II Study of Lenalidomide Combined with Cetuximab in Refractory KRAS-Mutant Metastatic Colorectal Cancer Patients

  2013cited by this paper
• MRI and MRS predictors of mild cognitive impairment in a population-based sample

  2013cited by this paper
• Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal aging

  2013cited by this paper
• Cerebrospinal fluid biomarkers in Alzheimer’s disease, vascular dementia and ischemic stroke patients: a critical analysis

  2013influential reference
• Designing drug trials for Alzheimer's disease: What we have learned from the release of the phase III antibody trials: A report from the EU/US/CTAD Task Force

  2013cited by this paper
• Cerebrovascular disease and mechanisms of cognitive impairment: evidence from clinicopathological studies in humans.

  2012cited by this paper
• A hitchhiker's guide to diffusion tensor imaging

  2012cited by this paper
• PET amyloid-beta imaging in preclinical Alzheimer's disease.

  2012cited by this paper
• Risk factors and neurodegenerative mechanisms in stroke related dementia.

  2012cited by this paper
• Diffusion tensor imaging of the hippocampus and verbal memory performance: The RUN DMC Study

  2012cited by this paper
• Oxytocin-Motivated Ally Selection is Moderated by Fetal Testosterone Exposure and Empathic Concern

  2012cited by this paper
• Methodological challenges in designing dementia prevention trials - the European Dementia Prevention Initiative (EDPI).

  2012influential reference
• Prediction of conversion from mild cognitive impairment to Alzheimer's disease dementia based upon biomarkers and neuropsychological test performance.

  2012cited by this paper
• A primary study of diffusion tensor imaging-based histogram analysis in vascular cognitive impairment with no dementia.

  2011cited by this paper
• MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping

  2011cited by this paper
• Alzheimer's disease.

  2011cited by this paper
• Risk of Alzheimer's disease incidence attributable to vascular disease in the population

  2011cited by this paper
• White matter hyperintensities and cognition: testing the reserve hypothesis.

  2011cited by this paper
• Vascular Contributions to Cognitive Impairment and Dementia: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association

  2011cited by this paper
• Correlations between MRI white matter lesion location and executive function and episodic memory

  2011cited by this paper
• AHA / ASA Scientific Statement Vascular Contributions to Cognitive Impairment and Dementia

  2011cited by this paper
• O3‐06‐06: The Projected impact of risk factor reduction on Alzheimer's disease prevalence

  2011cited by this paper
• Transient Ischemic Attack and Stroke Can Be Differentiated by Analyzing the Diffusion Tensor Imaging

  2011influential reference
• The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics

  2011cited by this paper
• Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2′ mapping

  2011cited by this paper
• Vascular Dementia

  2011cited by this paper
• Epidemiological Neuropathology: The MRC Cognitive Function and Aging Study Experience

  2011cited by this paper
• Power Calculations for Clinical Trials in Alzheimer's Disease

  2011cited by this paper
• An introduction to diffusion tensor image analysis.

  2011cited by this paper
• White Matter Hyperintensity Burden and Susceptibility to Cerebral Ischemia

  2010cited by this paper
• Alzheimer's Disease Neuroimaging Initiative (ADNI)

  2010cited by this paper
• Alzheimer disease.

  2010cited by this paper
• Diffusion Tensor Imaging Changes Correlate with Cognition Better than Conventional MRI Findings in Patients with Subcortical Ischemic Vascular Disease

  2010cited by this paper
• The clinical use of structural MRI in Alzheimer disease

  2010cited by this paper
• Clinical core of the Alzheimer's disease neuroimaging initiative: Progress and plans

  2010cited by this paper
• Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment.

  2010cited by this paper
• Robust atrophy rate measurement in Alzheimer's disease using multi-site serial MRI: Tissue-specific intensity normalization and parameter selection

  2010cited by this paper
• Report of the task force on designing clinical trials in early (predementia) AD

  2010cited by this paper

• Programmable embedded bioprinting for one-step manufacturing of arterial models with customized contractile and metabolic functions.

  2025cites this paper
• New mechanisms of aging: from vascular to neurological system

  2025cites this paper
• Piracetam attenuates oxidative stress and inflammation-induced neuronal cell death in rats with vascular dementia potentially via the activation of the AMPK/SIRT-1/Nrf-2 signaling pathway

  2025cites this paper
• Development of a multistage classifier for early prediction of alzheimer’s disease

  2025cites this paper
• The association between dual sensory impairment and dementia: a meta-analysis and systematic review of the literature

  2025cites this paper
• Global trends in Alzheimer’s disease and other dementias: A comprehensive analysis of incidence, socio-demographic variations, and future projections

  2025cites this paper
• Trajectories of cognitive decline among patients with neurocognitive disorder: A seven-year retrospective cohort

  2025cites this paper
• Evaluating Machine Learning Algorithms for Early Detection of Alzheimer's Disease

  2025cites this paper
• Trends and Disparities in Dementia Among Older Adults With Coronary Artery Disease, 1999–2023: Insights From the CDC WONDER Database

  2025cites this paper
• Technology-Enabled Cognitive Strategy Intervention for Secondary Stroke Prevention: A Feasibility Study

  2025cites this paper
• Cognitive Aging Revisited: A Cross-Sectional Analysis of the WAIS-5

  2025cites this paper
• Identifying lifestyle risk factors that discriminate memory trajectories: Differential findings across racial and ethnic groups in older adults.

  2025cites this paper
• White matter tract correlations with spoken language in cerebrovascular disease

  2025cites this paper
• NHANES-based machine learning for cognitive impairment classification and blood and hearing threshold characterization in age-related hearing loss.

  2025cites this paper
• The Gut-Brain Axis in Alzheimer’s Disease: Exploring Microbial Influences and Therapeutic Strategies

  2025cites this paper
• Early Stage Prediction of Alzheimer's Disease via Machine Learning Models

  2025cites this paper
• Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia.

  2025cites this paper
• Brain frailty associated with stroke events in anterior circulation large artery occlusion

  2024cites this paper
• Hypertension and Cognitive Disorders.

  2024cites this paper
• Association Between Cognitive Function and Emotion, Sleep, Frailty, and Nutrition in Hospitalized Patients

  2024cites this paper
• SINGLE CASE EXPERIMENTAL DESIGN AS A TOOL FOR ASSESSING INDIVIDUALS WITH ALZHEIMER'S DISEASE

  2024cites this paper
• Target Trial Emulation Using Cohort Studies: Estimating the Effect of Antihypertensive Medication Initiation on Incident Dementia

  2024cites this paper
• Immersive Virtual Reality Cognitive Training for Improving Cognition and Depressive Symptoms Among Older Adults. Current Evidence and Future Recommendations. A Systematic Review

  2024cites this paper
• Radiographic Knee Osteoarthritis Is a Risk Factor for the Development of Dementia: Locomotive Syndrome and Health Outcomes in the Aizu Cohort Study

  2024cites this paper
• Mechanisms of mitophagy and oxidative stress in cerebral ischemia–reperfusion, vascular dementia, and Alzheimer’s disease

  2024cites this paper
• Association of Depression and Cognitive Performance in US Older Adults: A Secondary Analysis of Cross-Sectional Data Using NHANES 2013–2014

  2024cites this paper
• Blood–Brain Barrier Permeability Is Associated With Cognitive Functioning in Normal Aging and Neurodegenerative Diseases

  2024cites this paper
• Cognitive impairment in young and middle‐aged patients with acute heart failure

  2024cites this paper
• Pharmacokinetic evaluation of donanemab for the treatment of Alzheimer’s

  2024cites this paper
• A machine learning model for Alzheimer's disease prediction

  2024cites this paper
• Uric acid levels and their association with vascular dementia and Parkinson’s disease dementia: a meta-analysis

  2023cites this paper
• Machine Learning-Based Alzheimer's Disease Prediction using Textual Data

  2023cites this paper
• Deep learning applications in vascular dementia using neuroimaging

  2023cites this paper
• The relationship of small vessel disease burden on cerebral and regional brain atrophy rates and cognitive performance over one year of follow-up after transient ischemic attack

  2023cites this paper
• Age at Diagnosis of Atrial Fibrillation and Incident Dementia

  2023cites this paper
• A two-sample Mendelian randomization study of atherosclerosis and dementia

  2023influential citation
• Language Impairment in Vascular Dementia: A Clinical Review

  2023cites this paper
• Importance of oral health in mental health disorders: An updated review

  2023cites this paper
• Functional social isolation mediates the association between depression and executive function in older women: findings from the Canadian Longitudinal Study on Aging Comprehensive cohort

  2023cites this paper
• Imaging, Genetic, and Pathological Features of Vascular Dementia

  2023cites this paper
• Tocotrienol-Rich Fraction Ameliorates the Aluminium Chloride-Induced Neurovascular Dysfunction-Associated Vascular Dementia in Rats

  2023cites this paper
• Predicting the Risk of Alzheimer’s Disease and Related Dementia in Patients with Mild Cognitive Impairment Using a Semi-Competing Risk Approach

  2023cites this paper
• Pathophysiological Association of Alzheimer’s Disease and Hypertension: A Clinical Concern for Elderly Population

  2023cites this paper
• Exploring what progress is being made in the development of health promotion material for vascular dementia: A systematic review of the evidence

  2023cites this paper
• Arterial spin labelling reveals multi-regional cerebral hypoperfusion in patients with transient ischemic attack that are unrelated to ischemia location: A proof-of-concept study

  2023cites this paper
• Educational Attainment and Dementia: Mediation by Mid‐Life Vascular Risk Factors

  2023cites this paper
• Alzheimer’s Disease Neuropathologic Change and Vitamin Supplement Use Decades Earlier

  2023cites this paper
• Exposure to ultrafine particles and cognitive decline among older people in the United States.

  2023cites this paper
• Association between solid cooking fuel and cognitive decline: Three nationwide cohort studies in middle-aged and older population.

  2023cites this paper
• Sociodemographic Associations of Dementia Literacy in Older Australians

  2022cites this paper
• Economic Burden of Dementia Caused by Cardiovascular Disease in Australia

  2022cites this paper
• Recent Neurotherapeutic Strategies to Promote Healthy Brain Aging: Are we there yet?

  2022cites this paper
• Shared Molecular Mechanisms among Alzheimer’s Disease, Neurovascular Unit Dysfunction and Vascular Risk Factors: A Narrative Review

  2022cites this paper
• Early-Stage Alzheimer's Disease Prediction Using Machine Learning Models

  2022cites this paper
• The Cognitive Sequelae of Transient Ischemic Attacks—Recent Insights and Future Directions

  2022cites this paper
• Trigeminal Neuralgia Is a Dementia Risk Factor: A Retrospective Cohort Study

  2022cites this paper
• VEGF signalling causes stalls in brain capillaries and reduces cerebral blood flow in Alzheimer’s mice

  2022cites this paper
• The Relationship Between Cardiovascular Disease Risk Score and Postoperative Delirium: The PNDABLE Study

  2022cites this paper
• Interaction between Alzheimer’s Disease and Cerebral Small Vessel Disease: A Review Focused on Neuroimaging Markers

  2022cites this paper
• Potential Predictors for Cognitive Decline in Vascular Dementia: A Machine Learning Analysis

  2022cites this paper
• Preeclampsia and its relationship to pathological brain aging

  2022cites this paper
• The effect of brain gym and coffee oil treatment with cognitive functions on the elderly group in Padang Tualang Langkat District

  2022cites this paper
• Delivering Virtual Care to Patients with Cognitive Impairment within the Veterans Health Administration: Multi-level Barriers and Solutions

  2022cites this paper
• Current Pharmacotherapy and Multi-Target Approaches for Alzheimer’s Disease

  2022cites this paper
• Triglycerides as a Shared Risk Factor between Dementia and Atherosclerotic Cardiovascular Disease: A Study of 125 727 Individuals.

  2021cites this paper
• Modifiable risk factors for incident dementia and cognitive impairment: An umbrella review of evidence.

  2021cites this paper
• Association of Hearing Loss With Cognitive Decline in Alzheimer’s Disease and Vascular Dementia

  2021cites this paper
• Potentially Modifiable Risk Factors for Dementia in Lower- and Middle-Income Countries

  2021cites this paper
• Systems Biology and Chemoinformatics-Based Strategies to Explore the Biological Mechanism of Fugui Wenyang Decoction in Treating Vascular Dementia Rats

  2021cites this paper
• Neurovascular Alterations in Vascular Dementia: Emphasis on Risk Factors

  2021cites this paper
• Thromboxane A2 synthase inhibition ameliorates endothelial dysfunction, memory deficits, oxidative stress and neuroinflammation in rat model of streptozotocin diabetes induced dementia.

  2021cites this paper
• Vascular Dementia and Underlying Sex Differences

  2021cites this paper
• Association between coronary artery calcification and cognitive function in a Chinese community-based population

  2021cites this paper
• Atherosclerosis: The Culprit and Co-victim of Vascular Dementia

  2021cites this paper
• A protocol for systematic review and network meta-analysis

  2021cites this paper
• Lycopene supplementation protects vascular dementia gerbils against the impairment of learning and memory.

  2021cites this paper
• Rational design and synthesis of quinazoline derivatives

  2021cites this paper
• The Roles of Nitric Oxide Synthase/Nitric Oxide Pathway in the Pathology of Vascular Dementia and Related Therapeutic Approaches

  2021cites this paper
• Virtual Reality Exergames for Improving Older Adults' Cognition and Depression: A Systematic Review and Meta-analysis of Randomized Control Trials.

  2021cites this paper
• Annual Period Prevalence and Risk Factors of Dementia Among Older Jordanian Hospitalized Patients

  2021cites this paper
• Sociodemographic and Health-Related Factors Associated with Severity of Cognitive Impairment in Elderly Patients Hospital-ized in a Geriatric Clinic

  2021cites this paper
• ATVB IN FOCUS: Vascular Components of Cognitive Disorders

  2021cites this paper
• Increased risk of dementia in hypothyroidism: A Danish nationwide register‐based study

  2021cites this paper
• The neuroimaging of neurodegenerative and vascular disease in the secondary prevention of cognitive decline

  2021cites this paper
• Effectiveness comparisons of acupuncture treatments for vascular dementia

  2021cites this paper
• A Perspective on Multi-target Drugs for Alzheimer's Disease.

  2020cites this paper
• Dementia

  2020cites this paper
• The Impact of Low Hemoglobin Levels on Cognitive Brain Functions

  2020cites this paper
• Inhibition of peripheral VEGF signaling rapidly reduces leucocyte obstructions in brain capillaries and increases cortical blood flow in an Alzheimer’s disease mouse model

  2020cites this paper
• The Mediterranean style diet and cognition

  2020cites this paper
• Social Determinants of Health in Non-communicable Diseases: Case Studies from Japan

  2020cites this paper
• White matter tract microstructure and cognitive performance after transient ischemic attack

  2020influential citation
• A Systematic Review of the Association Between Psychological Stress and Dementia Risk in Humans

  2020cites this paper
• Effect of Obesity on Cognitive Impairment in Vascular Dementia Rat Model via BDNF-ERK-CREB Pathway

  2020cites this paper
• Prediction of poor clinical outcome in vascular cognitive impairment: TRACE‐VCI study

  2020cites this paper
• Low vision and the risk of dementia: a nationwide population-based cohort study

  2020cites this paper
• Low-dose X-ray imaging may increase the risk of neurodegenerative diseases.

  2020cites this paper
• Shared neural substrates of cognitive function and postural control in older adults

  2020cites this paper
• Current status and future prospects of pathophysiology-based neuroprotective drugs for the treatment of vascular dementia.

  2020cites this paper
• Targeting amyloid clearance in Alzheimer's disease as a therapeutic strategy

  2019cites this paper